The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Open accessAbstract
Current genome-editing technologies introduce double-stranded (ds) DNA breaks at a target locus as the first step to gene correction. Although most genetic diseases arise from point mutations, current approaches to point mutation correction are inefficient and typically induce an abundance of random insertions and deletions (indels) at the target locus resulting from the cellular response to dsDNA breaks. Here we report the development of 'base editing', a new approach to genome editing that enables the direct, irreversible conversion of one target DNA base into another in a programmable manner, without requiring dsDNA backbone cleavage or a donor template. We engineered fusions of CRISPR/Cas9 and a cytidine deaminase enzyme that retain the ability to be programmed with a guide RNA, do not induce dsDNA breaks, and mediate the direct conversion of cytidine to uridine, thereby effecting a C→T (or G→A) substitution. The resulting 'base editors' convert cytidines within a window of approximately five nucleotides, and can efficiently correct a variety of point mutations relevant to human disease. In four transformed human and murine cell lines, second- and third-generation base editors that fuse uracil glycosylase inhibitor, and that use a Cas9 nickase targeting the non-edited strand, manipulate the cellular DNA repair response to favour desired base-editing outcomes, resulting in permanent correction of ~15-75% of total cellular DNA with minimal (typically ≤1%) indel formation. Base editing expands the scope and efficiency of genome editing of point mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The discovery of spontaneous hydrolytic deamination of cytosine converting C-G base pairs to T-A in humans highlighted the potential of base editing for direct base pair conversion without requiring double-strand breaks or homology repair templates (Komor, et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor, et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the same paper, with enhanced third-generation base editors, Komor et al. achieved >30-fold greater editing efficiency in various human cell lines when compared to HDR-mediated Cas9 editing, with fewer indel formation.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“First-generation base editors had limitations such as low efficiency and base excision repair (BER) activity that reversed edits (Komor et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Second-generation editors, such as APOBEC-XTEN-dCas9-UGI, added an uracil DNA glycosylase inhibitor (UGI) to improve C-to-T conversion (Komor et al., 2016) but still had <0.1% indel formation, limiting precision (Azameti and Dauda, 2021).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Fusion of a cytidine deaminase (rAPOBEC1) to a partially inactive nickase-Cas9(D10A) protein results in a cytidine base editor (CBE) that allows for C > T base changes via a uracil intermediate28”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Coupling this Cas9n or dCas9, the catalytically “dead” variant of Cas9, with a cytidine deaminase enzyme enables the gRNA-mediated deamination of cytosine (C) bases in the non-target DNA strand into uracil (U), which shares the base-pairing properties of thymine (T) [82].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredIn the citing paper
“Variations on these methods enable the functional evaluation of genes (via knockout screens124), regulatory elements (using CRISPR interference and CRISPR activation screens125,126), and genetic variants (base editors127) at increasing scale and resolution29.”
From A brief history of human disease genetics (2020) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Flagged first, then by citations
1 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,035
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox
Koonin, E. V., Gootenberg, J. S., & Abudayyeh, O. O. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00159 · Cited by 95
Development of miniature base editors using engineered IscB nickase
Han, D., Xiao, Q., Wang, Y., Zhang, H., Dong, X., Li, G., Kong, X., Wang, S., Song, J., Zhang, W., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-01898-9 · Cited by 92
Fei, H., Li, Y., Liu, Y., Wei, J., Chen, A. A., & Gao, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.014 · Cited by 96
Generation of a Hutchinson–Gilford progeria syndrome monkey model by base editing
Wang, F., Zhang, W., Yang, Q., Kang, Y., Fan, Y., Wei, J., Liu, Z., Dai, S., Li, H., Li, Z., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00740-8 · Cited by 93
Improvements in Gene Editing Technology Boost Its Applications in Livestock
Périssé, I. V., Fan, Z., Singina, G. N., White, K. L., & Polejaeva, I. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.614688 · Cited by 88
CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
Chan, Y.-T., Lu, Y., Wu, J., Zhang, C., Tan, H., Bian, Z., Wang, N., & Feng, Y. (2022) · Theranostics · doi:10.7150/thno.71144 · Cited by 93
John van der, O. O. S. T., & Patinios, C. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.12.022 · Cited by 102
Hao, Y., Li, Q., Fan, C., & Wang, F. (2021) · Small Structures · doi:10.1002/sstr.202000046 · Cited by 90
The detection and functions of RNA modification m6A based on m6A writers and erasers
Zhang, W., Yang, Q., & Jia, G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100973 · Cited by 91
Highly efficient base editing in bacteria using a Cas9-cytidine deaminase fusion
Zheng, K., Wang, Y., Li, N., Jiang, F., Wu, C.-X., Liu, F., Chen, H., & Liu, Z. (2018) · Communications Biology · doi:10.1038/s42003-018-0035-5 · Cited by 89
Luo, Y., Ma, H., Zhang, S., Zheng, D., Che, P., Liu, X., Zhang, M., Gao, J., & Xu, J. C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b12117 · Cited by 89
Gene-specific mutagenesis enables rapid continuous evolution of enzymes in vivo
Park, H.-J., & Kim, S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1231 · Cited by 89
Simon, A. J., d’Oelsnitz, S., & Ellington, A. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0157-4 · Cited by 90
Vision rescue via unconstrained in vivo prime editing in degenerating neural retinas
Qin, H., Zhang, W., Zhang, S., Feng, Y., Xu, W., Jia, Q., Zhang, Q., Xu, C., Liu, S., Zhang, J., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220776 · Cited by 95
Cas9, Cpf1 and C2c1/2/3―What's next?
Nakade, S., Yamamoto, T., & Sakuma, T. (2017) · Bioengineered · doi:10.1080/21655979.2017.1282018 · Cited by 92
Efficient Gene Silencing by Adenine Base Editor-Mediated Start Codon Mutation
Wang, X., Liu, Z., Li, G., Dang, L., Huang, S., He, L., Ma, Y., Li, C., Liu, M., Yang, G., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.022 · Cited by 89
Base Editing in Plants: Applications, Challenges, and Future Prospects
Azameti, M. K., & Dauda, W. P. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.664997 · Cited by 88
Effective gene editing by high-fidelity base editor 2 in mouse zygotes
Liang, P., Sun, H., Sun, Y., Zhang, X., Xie, X., Zhang, J., Zhang, Z., Chen, Y., Ding, C., Xiong, Y., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0418-2 · Cited by 91
Self-citationDNA Base Excision Repair in Plants: An Unfolding Story With Familiar and Novel Characters
Roldán‐Arjona, T., Ariza, R. R., & Córdoba‐Cañero, D. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.01055 · Cited by 91
Engineering biosynthetic enzymes for industrial natural product synthesis
Galanie, S. S., Entwistle, D. A., & Lalonde, J. J. (2020) · Natural Product Reports · doi:10.1039/c9np00071b · Cited by 91
Genome editing in cereal crops: an overview
Matres, J. M., Hilscher, J., Datta, A., Armario-Nájera, V., Baysal, C., He, W., Huang, X., Zhu, C., کامران, ر. و., Trijatmiko, K. R., et al. (2021) · Transgenic Research · doi:10.1007/s11248-021-00259-6 · Cited by 90
Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
Tao, J., Wang, Q., Mendez‐Dorantes, C., Burns, K. H., & Chiarle, R. (2022) · Nature Communications · doi:10.1038/s41467-022-31322-3 · Cited by 91
Glycosylase-based base editors for efficient T-to-G and C-to-G editing in mammalian cells
Ye, L., Zhao, D., Li, J., Wang, Y., Li, B., Yang, Y., Hou, X., Wang, H., Wei, Z., Liu, X., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02050-w · Cited by 91
CRISPR Approaches to Small Molecule Target Identification
Jost, M., & Weissman, J. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00965 · Cited by 88
Tian, R., Liu, Y., Chen, J., Li, J., Liu, L., Du, G., & Chen, J. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.07.001 · Cited by 87
Attaining the promise of plant gene editing at scale
Nasti, R. A., & Voytas, D. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004846117 · Cited by 90
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Awwad, S. W., Serrano-Benítez, A., Thomas, J. C., Gupta, V., & Jackson, S. P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00571-x · Cited by 93
Efficient high-precision homology-directed repair-dependent genome editing by HDRobust
Riesenberg, S., Kanis, P., Macak, D., Wollny, D., Düsterhöft, D., Kowalewski, J., Helmbrecht, N., Maričić, T., & Pääbo, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01949-1 · Cited by 87
Precise genome-wide base editing by the CRISPR Nickase system in yeast
Satomura, A., Nishioka, R., Mori, H., Sato, K., Kuroda, K., & Ueda, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02013-7 · Cited by 89
Development and Application of Base Editors
Yang, B., Yang, L. C., & Chen, J. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0001 · Cited by 87
CRISPR-mediated accelerated domestication of African rice landraces
Lacchini, E., Kiegle, E., Castellani, M., Adam, H., Jouannic, S., Gregis, V., & Kater, M. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229782 · Cited by 86
Álvarez, B., Mencía, M., de Lorenzo, V., & Fernández, L. Á. (2020) · Nature Communications · doi:10.1038/s41467-020-20230-z · Cited by 89
Base and Prime Editing Technologies for Blood Disorders
Antoniou, P., Miccio, A., & Brusson, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618406 · Cited by 94
Transcription factor competition at the γ-globin promoters controls hemoglobin switching
Liu, N., Xu, S., Yao, Q., Zhu, Q., Yan, K., Hsu, J. Y., Sakon, P., Pinello, L., Yuan, G., Bauer, D. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00798-y · Cited by 86
Tabassum, J., Ahmad, S., Hussain, B., Mawia, A. M., Zeb, A., & Ju, L. (2021) · Agronomy · doi:10.3390/agronomy11071359 · Cited by 88
Volke, D. C., Martino, R. A., Kozaeva, E., Smania, A. M., & Nikel, P. I. (2022) · Nature Communications · doi:10.1038/s41467-022-30780-z · Cited by 89
Therapeutic adenine base editing of human hematopoietic stem cells
Liao, J., Chen, S., Hsiao, S., Jiang, Y., Yang, Y., Zhang, Y., Wang, X., Lai, Y., Bauer, D. E., & Wu, Y. (2023) · Nature Communications · doi:10.1038/s41467-022-35508-7 · Cited by 89
Bastet, A., Lederer, B., Giovinazzo, N., Arnoux, X., German‐Retana, S., Reinbold, C., Brault, V., Garcia, D., Djennane, S., Gersch, S., et al. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12896 · Cited by 86
Advanced domestication: harnessing the precision of gene editing in crop breeding
Lyzenga, W. J., Pozniak, C. J., & Kagale, S. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13576 · Cited by 85
Kim, J. (2016) · Nature Protocols · doi:10.1038/nprot.2016.104 · Cited by 89
Beyond Native Cas9: Manipulating Genomic Information and Function
Mitsunobu, H., Teramoto, J., Nishida, K., & Kondo, A. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.004 · Cited by 87
Genome editing and plant transformation of solanaceous food crops
Eck, J. M. V. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.07.012 · Cited by 88
In situ readout of DNA barcodes and single base edits facilitated by in vitro transcription
Askary, A., Sánchez-Guardado, L. Ó., Linton, J. M., Chadly, D. M., Budde, M. W., Cai, L., Lois, C., & Elowitz, M. B. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0299-4 · Cited by 86
CRISPR–Cas9, CRISPRi and CRISPR-BEST-mediated genetic manipulation in streptomycetes
Tong, Y., Whitford, C. M., Blin, K., Jørgensen, T. S., Weber, T., & Lee, S. Y. (2020) · Nature Protocols · doi:10.1038/s41596-020-0339-z · Cited by 85
Progress and challenges in sorghum biotechnology, a multipurpose feedstock for the bioeconomy
Silva, T. N., Thomas, J. B., Dahlberg, J., Rhee, S. Y., & Mortimer, J. C. (2021) · Journal of Experimental Botany · doi:10.1093/jxb/erab450 · Cited by 85
Yang, L., Zhang, X., Wang, L., Yin, S., Zhu, B., Xie, L., Duan, Q., Hu, H., Zheng, R., Yu, W., et al. (2018) · Protein & Cell · doi:10.1007/s13238-018-0568-x · Cited by 85
Liu, X., Zhang, P., Zhao, Q. L., & Huang, A. C. (2022) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13330 · Cited by 85
Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase
Tong, H., Liu, N., Wei, Y., Zhou, Y., Li, Y., Wu, D., Jin, M., Cui, S., Li, H., Li, G., et al. (2023) · National Science Review · doi:10.1093/nsr/nwad143 · Cited by 87
Raj, B., Gagnon, J. A., & Schier, A. F. (2018) · Nature Protocols · doi:10.1038/s41596-018-0058-x · Cited by 87
Cas9 off-target binding to the promoter of bacterial genes leads to silencing and toxicity
Rostain, W., Grebert, T., Vyhovskyi, D., Pizarro, P. T., Tshinsele-Van Bellingen, G., Cui, L., & Bikard, D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad170 · Cited by 85
Accurate analysis of genuine CRISPR editing events with ampliCan
Labun, K., Guo, X., Chavez, A., Church, G., Gagnon, J. A., & Valen, E. (2019) · Genome Research · doi:10.1101/gr.244293.118 · Cited by 84
Allogeneic CAR T cell therapies for leukemia
Qasim, W. (2019) · American Journal of Hematology · doi:10.1002/ajh.25399 · Cited by 86
Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides
Ding, X. L., Seebeck, T., Feng, Y., Jiang, Y., Davis, G. D., & Chen, F. (2019) · The CRISPR Journal · doi:10.1089/crispr.2018.0036 · Cited by 87
New molecular therapies for the treatment of hearing loss
Ma, Y., Wise, A. K., Shepherd, R. K., & Richardson, R. T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.003 · Cited by 86
Genetic Engineering and Editing of Plants: An Analysis of New and Persisting Questions
Mackelprang, R., & Lemaux, P. G. (2020) · Annual Review of Plant Biology · doi:10.1146/annurev-arplant-081519-035916 · Cited by 86
Precise, predictable multi-nucleotide deletions in rice and wheat using APOBEC–Cas9
Wang, S., Zong, Y., Lin, Q., Zhang, H., Chai, Z., Zhang, D., Chen, K., Qiu, J., & Gao, C. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0566-4 · Cited by 87
Engineering Gene Therapy: Advances and Barriers
Shahryari, A., Burtscher, I., Nazari, Z., & Lickert, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100040 · Cited by 87
Genome Editing for Sustainable Crop Improvement and Mitigation of Biotic and Abiotic Stresses
Hamdan, M. F., Karlson, C. K. S., Teoh, E. Y., Lau, S.-E., & Tan, B. C. (2022) · Plants · doi:10.3390/plants11192625 · Cited by 91
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Azeez, S. S., Hamad, R. S., Hamad, B., Shekha, M. S., & Bergsten, P. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1509924 · Cited by 88
Genome editing in crop improvement: Present scenario and future prospects
Miglani, G. S. (2017) · Journal of Crop Improvement · doi:10.1080/15427528.2017.1333192 · Cited by 86
Application and future perspective of CRISPR/Cas9 genome editing in fruit crops
Zhou, J., Li, D., Wang, G., Wang, F., Kunjal, M., Joldersma, D., & Liu, Z. (2019) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12793 · Cited by 86
Challenges and Perspectives in Homology-Directed Gene Targeting in Monocot Plants
Vu, T. V., Sung, Y. W., Kim, J., Tran, M. T., Tran, M. T., & Kim, J. (2019) · Rice · doi:10.1186/s12284-019-0355-1 · Cited by 83
Base editing with high efficiency in allotetraploid oilseed rape by A3A‐PBE system
Cheng, H., Hao, M., Ding, B., Mei, D., Wang, W., Wang, H., Zhou, R., Liu, J., Li, C., & Hu, Q. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13444 · Cited by 84
A detailed landscape of CRISPR-Cas-mediated plant disease and pest management
Karmakar, S., Das, P., Panda, D., Xie, K., Baig, M. J., & Molla, K. A. (2022) · Plant Science · doi:10.1016/j.plantsci.2022.111376 · Cited by 83
Scalable Functional Assays for the Interpretation of Human Genetic Variation
Tabet, D. R., Parikh, V. N., Mali, P., Roth, F. P., & Claussnitzer, M. (2022) · Annual Review of Genetics · doi:10.1146/annurev-genet-072920-032107 · Cited by 84
CRISPR/Cas9 Technology and Its Utility for Crop Improvement
Liu, H., Chen, W., Li, Y., Sun, L., Chai, Y., Chen, H., Nie, H., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810442 · Cited by 85
CRISPR-Cas: A robust technology for enhancing consumer-preferred commercial traits in crops
Verma, V., Kumar, A., Partap, M., Thakur, M., & Bhargava, B. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1122940 · Cited by 84
Potent and uniform fetal hemoglobin induction via base editing
Mayuranathan, T., Newby, G. A., Feng, R., Yao, Y., Mayberry, K. D., Lazzarotto, C. R., Li, Y., Levine, R. M., Nimmagadda, N., Dempsey, E., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01434-7 · Cited by 86
Self-citationClick editing enables programmable genome writing using DNA polymerases and HUH endonucleases
da Silva, J. F., Tou, C. J., King, E. M., Eller, M. L., Rufino‐Ramos, D., Ma, L., Cromwell, C. R., Metović, J., Benning, F. M. C., Chao, L. H., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02324-x · Cited by 86
DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA
Zheng, Y., Lorenzo, C., & Beal, P. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx050 · Cited by 85
Lopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82
A New Zealand Perspective on the Application and Regulation of Gene Editing
Fritsche, S., Poovaiah, C. R., MacRae, E., & Thorlby, G. J. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01323 · Cited by 86
Targeting fidelity of adenine and cytosine base editors in mouse embryos
Lee, H., Willi, M., Miller, S. M., Kim, S., Liu, C., Liu, D. R., & Hennighausen, L. G. (2018) · Nature Communications · doi:10.1038/s41467-018-07322-7 · Cited by 82
Self-citationHearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin
Tang, H., Wang, H., Wang, S., Hu, S. W., Lv, J., Xun, M., Gao, K., Wang, F., Chen, Y., Wang, D., et al. (2022) · Human Genetics · doi:10.1007/s00439-022-02504-2 · Cited by 86
Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
Jeong, S. H., Lee, H. J., & Lee, S. J. (2023) · The Journal of Microbiology · doi:10.1007/s12275-022-00005-5 · Cited by 88
Martin, A. S., Salamango, D. J., Serebrenik, A. A., Shaban, N. M., Brown, W. L., Donati, F., Munagala, U., Conticello, S. G., & Harris, R. S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky332 · Cited by 81
Nadakuduti, S. S., Buell, C. R., Voytas, D. F., Starker, C. G., & Douches, D. S. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01607 · Cited by 81
Genome editing methods in animal models
Lee, H., Yoon, D. E., & Kim, K. (2020) · Animal Cells and Systems · doi:10.1080/19768354.2020.1726462 · Cited by 83
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Turnham, D. J., Bullock, N., Dass, M. S., Staffurth, J. N., & Pearson, H. B. (2020) · Cells · doi:10.3390/cells9112342 · Cited by 85
Expanding the plant genome editing toolbox with recently developed CRISPR–Cas systems
Wada, N., Osakabe, K., & Osakabe, Y. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac027 · Cited by 83
CRISPR Therapeutics for Duchenne Muscular Dystrophy
Erkut, E. J. N., & Yokota, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031832 · Cited by 82
Engineering approaches for RNA-based and cell-based osteoarthritis therapies
DeJulius, C. R., Walton, B. L., Colazo, J. M., d’Arcy, R., Francini, N., Brunger, J. M., & Duvall, C. L. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01067-4 · Cited by 85
Enhancement of specialized metabolites using CRISPR/Cas gene editing technology in medicinal plants
Das, S., Kwon, M., & Kim, J. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1279738 · Cited by 82
Gu, T., Zhao, S., Pi, Y., Chen, W., Chen, C., Liu, Q., Li, M., Han, D., & Ji, Q. (2018) · Chemical Science · doi:10.1039/c8sc00637g · Cited by 81
Tan, J., Zeng, D., Zhao, Y., Wang, Y., Liu, T., Li, S., Xue, Y., Luo, Y., Xie, X., Chen, L., et al. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13774 · Cited by 80
Raveux, A., Vandormael‐Pournin, S., & Cohen‐Tannoudji, M. (2017) · Scientific Reports · doi:10.1038/srep42661 · Cited by 81
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Liu, B., Saber, A., & Haisma, H. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.011 · Cited by 86
Application of the CRISPR/Cas system for genome editing in microalgae
Zhang, Y., Jiang, J., Shi, T., Sun, X., Zhao, Q., Huang, H., & Ren, L. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09726-x · Cited by 82
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs
Coelho, M. A., Braekeleer, E. D., Firth, M. A., Biśta, M., Łukasiak, S., Cuomo, M. E., & Taylor, B. (2020) · Nature Communications · doi:10.1038/s41467-020-17952-5 · Cited by 84
Precise genome-editing in human diseases: mechanisms, strategies and applications
Zheng, Y., Li, Y., Zhou, K., Li, T., VanDusen, N. J., & Hua, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01750-2 · Cited by 91
Engineering and optimising deaminase fusions for genome editing
Yang, L., Briggs, A. W., Chew, W. L., Mali, P., Güell, M., Aach, J., Goodman, D. B., Cox, D. B. T., Kan, Y., Lesha, E., et al. (2016) · Nature Communications · doi:10.1038/ncomms13330 · Cited by 79
Gramazio, P., Takayama, M., & Ezura, H. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.577980 · Cited by 79
Thermoreversible Control of Nucleic Acid Structure and Function with Glyoxal Caging
Knutson, S. D., Sanford, A. A., Swenson, C., Korn, M. M., Manuel, B. A., & Heemstra, J. M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c08996 · Cited by 79
Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation
Chu, S. H., Packer, M. S., Rees, H. A., Lam, D. K., Yu, Y., Marshall, J., Cheng, L.-I., Lam, D., Olins, J., Ran, F. A., et al. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0144 · Cited by 79
Self-citationGene therapy for cystic fibrosis: new tools for precision medicine
Lee, J. A., Cho, A., Huang, E. N., Xu, Y., Quach, H., Hu, J., & Wong, A. P. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03099-4 · Cited by 94
Multiplex base- and prime-editing with drive-and-process CRISPR arrays
Yuan, Q., & Gao, X. (2022) · Nature Communications · doi:10.1038/s41467-022-30514-1 · Cited by 85
He, Y., Zhou, X., Chang, C. H., Chen, G., Liu, W., Li, G., Fan, X., Sun, M., Miao, C., Huang, Q., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.01.021 · Cited by 79
Revolutionizing CRISPR technology with artificial intelligence
Kim, M., Go, M.-J., Kang, S.-H., Jeong, S.-H., & Lim, K. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01462-9 · Cited by 87
Genotyping genome‐edited mutations in plants using CRISPR ribonucleoprotein complexes
Liang, Z., Chen, K., Yan, Y., Zhang, Y., & Gao, C. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12938 · Cited by 83
CRISPR/Cas9-Mediated Adenine Base Editing in Rice Genome
Li, H., Ruiying, Q., Liu, X., Shengxiang, L., Xu, R., Jianbo, Y., & Pengcheng, W. (2019) · Rice Science · doi:10.1016/j.rsci.2018.07.002 · Cited by 78
Metadata
- Authors
- Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- Venue
- Nature
- Published
- 2016-04-20
- Volume
- 533
- Issue
- 7603
- Pages
- 420-424
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4873371
- OpenAlex
- W2336828812
- Cited by
- 5,437
- References
- 36
- Citations by year
- 2026: 564 · 2025: 660 · 2024: 664 · 2023: 719 · 2022: 681 · 2021: 614 · 2020: 540 · 2019: 408 · 2018: 338 · 2017: 182 · 2016: 61
- FWCI
- 171.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences (T32GM008313, F32 GM 106601-2, F32GM106601, F32 GM 112366-2, R01GM065400, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- base editing, CRISPR/Cas9, cytidine deaminase, point mutation correction, Cas9 nickase, DNA repair, guide RNA, genome editing, human disease models
- MeSH terms
- APOBEC-1 Deaminase, RNA, Guide, CRISPR-Cas Systems, Animals, Base Sequence, Cell Line, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, DNA Repair, Genetic Engineering, Humans, Templates, Genetic, Uridine, Genes, p53, Genome, Point Mutation, Mice, Uracil-DNA Glycosidase, Apolipoprotein E4, DNA Cleavage, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
